167 related articles for article (PubMed ID: 37664851)
21. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
Wong CK; Lam CL; Wan YF; Rowen D
Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
[TBL] [Abstract][Full Text] [Related]
22. Predicting SF-6D utility scores from the neck disability index and numeric rating scales for neck and arm pain.
Carreon LY; Anderson PA; McDonough CM; Djurasovic M; Glassman SD
Spine (Phila Pa 1976); 2011 Mar; 36(6):490-4. PubMed ID: 20847713
[TBL] [Abstract][Full Text] [Related]
23. Use of Bayesian methods to model the SF-6D health state preference based data.
Kharroubi SA
Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
[TBL] [Abstract][Full Text] [Related]
24. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
25. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
Ara R; Brazier J
Value Health; 2009; 12(2):346-53. PubMed ID: 18647248
[TBL] [Abstract][Full Text] [Related]
26. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
[TBL] [Abstract][Full Text] [Related]
27. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
28. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.
Lee L; Kaneva P; Latimer E; Feldman LS
J Surg Res; 2014 Jan; 186(1):135-41. PubMed ID: 24021906
[TBL] [Abstract][Full Text] [Related]
29. Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg).
Sun S; Stenberg E; Cao Y; Lindholm L; Salén KG; Franklin KA; Luo N
Eur J Health Econ; 2023 Mar; 24(2):279-292. PubMed ID: 35596099
[TBL] [Abstract][Full Text] [Related]
30. Mapping between headache specific and generic preference-based health-related quality of life measures.
Khan K; Mistry H; Matharu M; Norman C; Petrou S; Stewart K; Underwood M; Achana F
BMC Med Res Methodol; 2022 Oct; 22(1):277. PubMed ID: 36289468
[TBL] [Abstract][Full Text] [Related]
31. Predicting SF-6D utility scores from the Oswestry disability index and numeric rating scales for back and leg pain.
Carreon LY; Glassman SD; McDonough CM; Rampersaud R; Berven S; Shainline M
Spine (Phila Pa 1976); 2009 Sep; 34(19):2085-9. PubMed ID: 19730215
[TBL] [Abstract][Full Text] [Related]
32. Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39.
Chen G; Iezzi A; McKie J; Khan MA; Richardson J
Diabetes Res Clin Pract; 2015 Aug; 109(2):326-33. PubMed ID: 26013567
[TBL] [Abstract][Full Text] [Related]
33. Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy.
Flint I; Medjedovic J; Drogon O'Flaherty E; Alvarez-Baron E; Thangavelu K; Savic N; Meunier A; Longworth L
Eur J Health Econ; 2023 Sep; 24(7):1061-1072. PubMed ID: 36260149
[TBL] [Abstract][Full Text] [Related]
34. Mapping health assessment questionnaire disability index onto EQ-5D-5L in China.
Wan C; Wang Q; Xu Z; Huang Y; Xi X
Front Public Health; 2023; 11():1123552. PubMed ID: 37143986
[TBL] [Abstract][Full Text] [Related]
35. Mapping the disease-specific LupusQoL to the SF-6D.
Meacock R; Harrison M; McElhone K; Abbott J; Haque S; Bruce I; Teh LS
Qual Life Res; 2015 Jul; 24(7):1749-58. PubMed ID: 25510215
[TBL] [Abstract][Full Text] [Related]
36. Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data.
Philipson A; Hagberg L; Hermansson L; Karlsson J; Ohlsson-Nevo E; Ryen L
Pharmacoecon Open; 2023 Sep; 7(5):765-776. PubMed ID: 37322384
[TBL] [Abstract][Full Text] [Related]
37. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
38. Does Selecting Covariates Using Factor Analysis in Mapping Algorithms Improve Predictive Accuracy? A Case of Predicting EQ-5D-5L and SF-6D Utilities from the Women's Health Questionnaire.
Kaambwa B; Smith C; de Lacey S; Ratcliffe J
Value Health; 2018 Oct; 21(10):1205-1217. PubMed ID: 30314622
[TBL] [Abstract][Full Text] [Related]
39. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
[TBL] [Abstract][Full Text] [Related]
40. The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.
Kontodimopoulos N
Qual Life Res; 2015 Jun; 24(6):1535-44. PubMed ID: 25391489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
